• CHK1 Inhibition in Breast Cancer: ER/PR-Dependent Effects

  2026-08-14

  This study shows that CHK1 inhibition cannot be applied uniformly across breast cancer subtypes: it enhances adriamycin sensitivity in ER−/PR−/HER2− disease but acts mainly as a single-agent strategy in ER+/PR+/HER2− cells. By integrating receptor stratification, functional assays, and transcriptome analysis, the work links these divergent responses to distinct checkpoint, mitotic, and apoptotic mechanisms.

• Imatinib (STI571) in Hypoxia-Linked Kinase Research

  2026-08-14

  Imatinib (STI571) offers a precise way to interrogate Abl, PDGF receptor, and c-Kit signaling in erythroleukemia models. This article translates recent HIF/GATA1 findings into a context-aware assay strategy for cancer biology research and kinase pathway interpretation.

• 3-Deazaadenosine Hydrochloride in Fibrosis

  2026-08-13

  A mechanistic and translational guide to using 3-Deazaadenosine hydrochloride as an S-adenosylhomocysteine hydrolase inhibitor for methylation, hepatic stellate cell, inflammation, and fibrosis research.

• RSL3–PARP1 Crosstalk in Ferroptosis and Apoptosis

  2026-08-13

  The reference study shows that RSL3 connects ferroptosis to apoptosis through two coordinated PARP1-regulatory mechanisms: caspase-dependent cleavage and depletion of full-length PARP1 through altered METTL3-mediated m6A regulation. These findings clarify how an established ferroptosis inducer can retain pro-apoptotic activity in PARP inhibitor-resistant cancer models and provide a framework for combining cell-death pathway analysis with direct caspase activity measurement.

• Moxifloxacin Workflows for Toxicity and Gyrase Research

  2026-08-12

  Moxifloxacin supports a connected research workflow spanning bacterial DNA gyrase assays, retinal ganglion cell viability studies, and systemic toxicity models. This guide emphasizes concentration control, mechanism-aware readouts, and troubleshooting strategies that help distinguish antibacterial activity from mammalian or metabolic stress.

• EMD638683: SGK1 Inhibitor Evidence and Workflows

  2026-08-12

  EMD638683 is a selective SGK1 inhibitor for mechanistic studies of sodium-channel signaling, endothelial stiffness, NDRG1 phosphorylation, and tumor-cell responses. Biochemical, cellular, animal, and vascular-model evidence supports research use, while assay-dependent potency and limited translational evidence define its boundaries.

• H-89: A Causal Map for PKA Signaling Assays

  2026-08-11

  H-89 is a cAMP-dependent protein kinase inhibitor that can help separate PKA-dependent signaling from downstream metabolic and phenotypic effects. This article develops a time-aware assay strategy connecting H-89 use with Wnt-driven O-GlcNAcylation, glycolysis, and osteoblast function.

• p-tau Ser356 and NUAK Inhibition in Alzheimer’s

  2026-08-11

  Taylor et al. characterize tau phosphorylated at Ser356 as a pathology-associated species that increases with Alzheimer’s disease progression, appears in neurofibrillary tangles, and localizes near synapses. Their ex vivo experiments show that WZ4003 lowers p-tau Ser356 in human brain slices, while mouse slices display broader, culture-dependent reductions in tau and neuronal proteins, highlighting important model-specific constraints.

• CBD and Endocannabinoid Mechanisms in Orofacial Pain

  2026-08-10

  This 2026 reference study shows that cannabidiol reduces both sensory pain and pain-associated affective and cognitive deficits in mouse inflammatory pain models. Its main contribution is a multilevel mechanistic framework linking peripheral CB2 signaling, central CB1 pathways, inflammatory and oxidative control, and serotonin dynamics in the central amygdala.

• IGF2BP1–TUBB4B Axis in Liver Fibrosis

  2026-08-09

  The reference study identifies an m6A-dependent IGF2BP1/TUBB4B/FAK pathway that promotes hepatic stellate cell activation, proliferation, and migration. Its integrated transcriptomic and molecular approach provides a mechanistic framework for studying methylation-linked fibrogenesis and evaluating pathway-level interventions.

• Indazole Glucagon Receptor Antagonists in T2D

  2026-08-08

  The 2015 study reports an indazole- and indole-based series of glucagon receptor antagonists developed from the pyrazole lead MK-0893. Structure–activity relationship studies identified potent compounds with favorable rat pharmacokinetics, while GRA 16d reduced glucagon-driven glucose excursions in humanized GCGR mouse models after oral dosing.

• Protease Inhibitor Cocktail for OXPHOS Assays

  2026-08-07

  Protect intact signaling and mitochondrial proteins during cell and tissue extraction with an EDTA-free, broad-spectrum formulation suited to Western blotting, Co-IP, pull-down, and kinase workflows. This practical guide connects protease control with the dual-genome OXPHOS findings reported in recent cancer research.

• SB743921: Selective Kinesin Spindle Protein Inhibitor for Ca

  2026-08-07

  SB743921 is a highly potent and selective kinesin spindle protein inhibitor with nanomolar activity in cancer cell lines and preclinical xenograft models. It induces mitotic arrest and apoptosis, facilitating precise dissection of anti-proliferative effects in cancer research. This article details its mechanism, efficacy benchmarks, and workflow integration with direct links to reference data.

• Ganetespib (STA-9090) in Cancer Research: Workflows & Insigh

  2026-08-06

  Ganetespib (STA-9090) empowers researchers with ultra-potent Hsp90 inhibition, driving rapid tumor growth suppression across diverse cancer models. This article translates cutting-edge findings and practical troubleshooting into streamlined workflows for advanced cell death and protein secretion studies.

• GLP-1 (9-36) Amide in GLP-1 Receptor Signaling Research

  2026-08-06

  GLP-1 (9-36) amide enables precision interrogation of the GLP-1 receptor pathway, revealing nonconventional signaling and receptor cross-talk. Researchers can leverage its unique antagonist profile to dissect metabolic and diabetes-related mechanisms with improved assay specificity.

15876 records 1/1059 page Next 12345 下5页 Last page